On March 17, 2023, Robert Ruffolo resigned as a director of Aridis Pharmaceuticals, Inc. (the Company). Following more than six years of service to the Company, Dr. Ruffolo is retiring for personal family reasons and from being a director on other boards that he served on.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 USD | +8.89% |
|
-21.57% | -14.41% |
Jun. 24 | Aridis Pharmaceuticals, Inc. Provides Corporate Update on Recent Developments | CI |
Jun. 24 | Aridis Pharmaceuticals, Inc. announced that it expects to receive $0.299 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-14.41% | 3.2M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- ARDS Stock
- News Aridis Pharmaceuticals, Inc.
- Aridis Pharmaceuticals, Inc. Announces the Resignation of Robert Ruffolo as Director